Long-term outcome of autologous haematopoietic stem cell transplantation in patients with systemic sclerosis: a comparison with patients treated with rituximab and with traditional immunosuppressive agents

MLA

Nicoletta Del Papa, et al. “Long-Term Outcome of Autologous Haematopoietic Stem Cell Transplantation in Patients with Systemic Sclerosis: A Comparison with Patients Treated with Rituximab and with Traditional Immunosuppressive Agents.” Arthritis Research & Therapy, vol. 26, no. 1, Oct. 2024, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s13075-024-03408-4.

APA

Nicoletta Del Papa, Silvia Cavalli, Andrea Rindone, Francesco Onida, Giorgia Saporiti, Antonina Minniti, Maria Rosa Pellico, Claudia Iannone, Giorgia Trignani, Nicoletta D’Angelo, Manuel Sette, Raffaella Greco, Claudio Vitali, & Roberto Caporali. (2024). Long-term outcome of autologous haematopoietic stem cell transplantation in patients with systemic sclerosis: a comparison with patients treated with rituximab and with traditional immunosuppressive agents. Arthritis Research & Therapy, 26(1), 1–10. https://doi.org/10.1186/s13075-024-03408-4

Chicago

Nicoletta Del Papa, Silvia Cavalli, Andrea Rindone, Francesco Onida, Giorgia Saporiti, Antonina Minniti, Maria Rosa Pellico, et al. 2024. “Long-Term Outcome of Autologous Haematopoietic Stem Cell Transplantation in Patients with Systemic Sclerosis: A Comparison with Patients Treated with Rituximab and with Traditional Immunosuppressive Agents.” Arthritis Research & Therapy 26 (1): 1–10. doi:10.1186/s13075-024-03408-4.